← Browse by Condition
Medical Condition

ebv t nk lpd

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for ebv t nk lpd sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4
1
Top Sponsors
Beijing Children's Hospital 1 trial
NCT07029958 Phase 4
Recruiting

Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease

Enrollment
48 pts
Location
China
Sponsor
Beijing Children's Hospital
View Trial →